Cargando…
Multimodal survival prediction in advanced pancreatic cancer using machine learning
BACKGROUND: Existing risk scores appear insufficient to assess the individual survival risk of patients with advanced pancreatic ductal adenocarcinoma (PDAC) and do not take advantage of the variety of parameters that are collected during clinical care. METHODS: In this retrospective study, we built...
Autores principales: | Keyl, J., Kasper, S., Wiesweg, M., Götze, J., Schönrock, M., Sinn, M., Berger, A., Nasca, E., Kostbade, K., Schumacher, B., Markus, P., Albers, D., Treckmann, J., Schmid, K.W., Schildhaus, H.-U., Siveke, J.T., Schuler, M., Kleesiek, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588888/ https://www.ncbi.nlm.nih.gov/pubmed/35988455 http://dx.doi.org/10.1016/j.esmoop.2022.100555 |
Ejemplares similares
-
A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma
por: Maßmann, M., et al.
Publicado: (2022) -
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer
por: Reissig, T.M., et al.
Publicado: (2023) -
Deep learning‐based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer
por: Keyl, Julius, et al.
Publicado: (2022) -
Impact of encorafenib on survival of patients with BRAF(V600E)-mutant metastatic colorectal cancer in a real-world setting
por: Zurloh, M., et al.
Publicado: (2023) -
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy
por: Rosery, Vivian, et al.
Publicado: (2022)